LDN Social Media
Get connected with us on social networks
Low-dose naltrexone shows promise for long COVID
New Zealand Doctor Rata Aotearoa
David Codyre
Wednesday 8 January 2025
Psychiatrist David Codyre reviews the growing evidence for low-dose naltrexone in the treatment of functional syndromes such as fibromyalgia, chronic fatigue and long COVID
Key points, In low doses (typically 3–4.5mg daily), naltrexone appears to modulate ...
Subscription required: Follow link i f you have, or want, a subscription to this medical website